1290 Disparities in time to treatment for Asian melanoma patients

Timeliness of melanoma treatment was compared between Asian American and Pacific Islander (AAPI) non-Hispanic White (NHW) patients. AAPI patients have lower likelihood survival once diagnosed present with later-stage melanoma. may play a key role in the disparity, as longer time from diagnosis to definitive surgery (TTDS) is associated increased melanoma-specific mortality. A retrospective analysis NHW National Cancer Database (2004-2020) performed. Multivariable logistic regression used evaluate association race TTDS, controlling for sociodemographic disease characteristics. Of 391,110 identified, 1388 (0.35%) were AAPI. had TTDS stage I, II, III (P < .001), but not IV, chemotherapy, immunotherapy, or radiotherapy > .05). After adjusting characteristics, over 1.5 times odds having 61 90 days nearly 2 days. Racial differences persisted among Medicare private insurance types. no longest (mean, 53.26 days), those shortest 34.92 days; P .001 both). more likely experience delays receiving curative than This disparity stages I-III, Medicare, insurance. Melanoma been identified Black patients, our findings reveal similar disparities population. Treatment socioeconomic should inform targeted efforts reduce disparities.